Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
16 Apr 2018 EMA to Review Risk of Dosing Errors with Methotrexate Anticancer agents & Biologic therapy
13 Apr 2018 ELCC 2018 News: New Data Support First-Line Osimertinib in Patients with NSCLC and Sensitising EGFR Mutation Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
13 Apr 2018 ELCC 2018 News: Low Baseline Endoglin Levels May Signal Improved Survival with Nintedanib in Malignant Pleural Mesothelioma Lung and other thoracic tumours - Translational research - Anticancer agents & Biologic therapy
13 Apr 2018 FDA Approves Everolimus for Tuberous Sclerosis Complex-Associated Partial-Onset Seizures Cancer in Special Situations
12 Apr 2018 Dual Targeting of BTK and BCL2 in Mantle-Cell Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy
12 Apr 2018 ELCC 2018 News: Second-line TKI Therapy Demonstrates Clinical Benefit in Patients with EGFR Mutated NSCLC and Leptomeningeal Metastasis Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
12 Apr 2018 ELCC 2018 News: Patients with Advanced Lung Adenocarcinoma and Complex EGFR Mutations Demonstrate Different Response Rates to TKI Therapy Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
11 Apr 2018 The PanCancer Atlas Completed Personalised medicine
10 Apr 2018 FDA Approves Rucaparib for Maintenance Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Gynaecologic malignancies - Personalised medicine - Anticancer agents & Biologic therapy
09 Apr 2018 Withdrawal of Application for a Change to the Marketing Authorisation for Aranesp (Darbepoetin Alfa) Haematologic malignancies - Palliative and supportive care
06 Apr 2018 Generic Medicine Pemetrexed Krka Received a Positive Opinion from the EMA Lung and other thoracic tumours - Anticancer agents & Biologic therapy
05 Apr 2018 Bioinformatics for Precision Cancer Medicine Personalised medicine
04 Apr 2018 EMA Recommends Granting a Marketing Authorisation for a Biosimilar Trastuzumab (Kanjinti) Breast cancer - Gastrointestinal cancers - Anticancer agents & Biologic therapy
03 Apr 2018 Increased Levels of Screening for Symptoms of Metabolic Syndrome Called for in Testicular Cancer Survivors Genitourinary cancers
30 Mar 2018 EMA Recommends Extension of Therapeutic Indications for Fosaprepitant Palliative and supportive care